Literature DB >> 373544

Legionnaires' disease in patients with associated serious disease.

D W Gump, R O Frank, W C Winn, R S Foster, C V Broome, W B Cherry.   

Abstract

Of nine patients with Legionnaires' disease, seven were receiving corticosteroids, and all nine had serious underlying diseases. Direct immunofluorescent examination of respiratory secretions, including sputum and transtracheal aspirates, showed the Legionnaires' disease (LD) bacterium in five of seven patients who seroconverted and in a sixth patient with a single elevated titer to the LD bacterium. All nine patients received erythromycin therapy, and five survived. Two patients showed persistence of their infection after receiving 2 weeks of erythromycin therapy, and two patients developed pulmonary abscesses. These cases of Legionnaires' disease show the occurrence of pulmonary abscesses, the possibility of relapse after giving only 2 weeks of erythromycin therapy, and the utility of direct immunofluorescence for early diagnosis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 373544     DOI: 10.7326/0003-4819-90-4-538

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  17 in total

Review 1.  Legionnaires disease: historical perspective.

Authors:  W C Winn
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

2.  Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila.

Authors:  A L Baltch; R P Smith; W Ritz
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

3.  Effects of alpha-amylase on in vitro growth of Legionella pneumophila.

Authors:  C A Bortner; R D Miller; R R Arnold
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

4.  Pronounced cerebellar features in legionnaires' disease.

Authors:  M R Maskill; E C Jordan
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-25

5.  Loculated pleural effusion caused by Legionella pneumophilia.

Authors:  A P Freedman; E Coodley; R F Johnston; L Goodman; S M Katz
Journal:  Thorax       Date:  1982-01       Impact factor: 9.139

6.  Effect of immunosuppressive therapy on the clinical presentation of legionellosis.

Authors:  K Skogberg; P Ruutu; I Koivula; H Jousimies-Somer; V Valtonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

7.  Antibacterial effects of levofloxacin, erythromycin, and rifampin in a human monocyte system against Legionella pneumophila.

Authors:  A L Baltch; R P Smith; M A Franke; P B Michelsen
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

8.  Direct immunofluorescent detection of Legionella pneumophila in respiratory specimens.

Authors:  W C Winn; W B Cherry; R O Frank; C A Casey; C V Broome
Journal:  J Clin Microbiol       Date:  1980-01       Impact factor: 5.948

9.  [Legionella pneumophila pneumonia masked by simultaneous demonstration of further non-specific pneumonia pathogens].

Authors:  U Dickgiesser; H E Müller; G Böhm; D Fritsche
Journal:  Infection       Date:  1985 Sep-Oct       Impact factor: 3.553

10.  Characterization, serological specificity, and diagnostic possibilities of monoclonal antibodies against Legionella pneumophila.

Authors:  J G Guillet; J Hoebeke; C Tram; S Marullo; A D Strosberg
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.